Sandesh Mahatme
2019
In 2019, Sandesh Mahatme earned a total compensation of $5.2M as Executive Vice President, Chief Financial Officer and Chief Business Officer at Sarepta Therapeutics, a 22% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $354,256 |
|---|---|
| Option Awards | $4,234,786 |
| Salary | $557,327 |
| Other | $14,840 |
| Total | $5,161,209 |
Mahatme received $4.2M in option awards, accounting for 82% of the total pay in 2019.
Mahatme also received $354.3K in non-equity incentive plan, $557.3K in salary and $14.8K in other compensation.
Rankings
In 2019, Sandesh Mahatme's compensation ranked 2,107th out of 13,971 executives tracked by ExecPay. In other words, Mahatme earned more than 84.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,107 out of 13,971 | 85th |
Division Manufacturing | 764 out of 5,698 | 87th |
Major group Chemicals And Allied Products | 236 out of 2,197 | 89th |
Industry group Drugs | 191 out of 1,883 | 90th |
Industry Pharmaceutical Preparations | 138 out of 1,395 | 90th |
Pay ratio
| Sandesh Mahatme's Pay | $5,161,209 |
|---|---|
| Median Employee's Pay | $290,714 |
| Pay Ratio | 18to 1 |
In 2019, the annual total compensation of Sandesh Mahatme was $5,161,209.
The annual total compensation of the median employee at Sarepta Therapeutics was $290,714.
The ratio of Sandesh Mahatme's pay to the pay of median employee was therefore 18 to one.
Source: SEC filing on April 21, 2020.
Mahatme's colleagues
We found four more compensation records of executives who worked with Sandesh Mahatme at Sarepta Therapeutics in 2019.